Restructurings, exit costs, and impairments under 8-K Items 2.05/2.06.
Lunai Bioworks Inc. announced a impairment.
“management determined on September 2, 2025 that a material impairment of assets has occurred. The Company expects to record an impairment charge for the quarter ending September 30, 2025, however, is unable to make a good faith estimate of the same or the cash expenditures resulting from the impairment charge, if any, at the time of this filing.”
Cerence Inc. announced a restructuring with charges of approximately $7.2 to $7.9 million affecting certain foreign operations.
“On September 2, 2025, Cerence Inc. (the “Company”) announced a restructuring plan with respect to certain foreign operations intended to further reduce operating expenses and position the Company for profitable future growth (the “Plan”). The Company estimates that it will incur cash restructuring charges of approximately $7.2 to $7.9 million in connection with the Plan, primarily consisting of severance payments, payments in lieu of notice, employee benefits and related costs.”
STANDARD BIOTOOLS INC. announced a restructuring with charges of approximately $3.6 million affecting R&D function (reduction-in-force of certain U.S. employees in the Company’s R&D function, including members of its management team).
“The Company currently expects expenses related to the reduction-in-force, consisting primarily of cash severance and termination benefits and related costs, to be approximately $3.6 million, which includes approximately $0.9 million of non-cash expenses related to vesting of share-based awards. These estimates are subject to a number of assumptions, and actual”
GREEN DOT CORP announced a restructuring with charges of Total costs of approximately $22 million to $24 million, including $18 million severance and termination benefits, $3 million to $5 million contract termination affecting China operations (up to approximately 240 employees, representing approximately 22% of the Company's global workforce).
“On September 2, 2025, Green Dot Corporation (the “Company”) announced a plan to exit the Company's operational activities in China by the end of 2025 as a means of reducing complexity and promoting long-term structural improvements for its business. This action will impact up to approximately 240 employees, representing approximately 22% of the Company’s global workforce. The Company also anticipates closing certain facilities in connection with the exit plan. The Company expects this exit plan to result in an estimated annual total reduction in spending of $6 million to $7 million, primarily through lower operating expenses and reductions in capitalized internal-use software costs. These actions are expected to be completed in 2025. The Company estimates that it will incur total costs in connection with its exit plan of approximately $22 million to $24 million, of which approximately $18 million is expected to be for severance and termination benefits, $3 million to $5 million is expe”
J&J SNACK FOODS CORP announced a restructuring with charges of between $12 million and $20 million affecting certain of its manufacturing plants.
“On August 28, 2025, J & J Snack Foods Corp. committed to a plan to strategically optimize the Company’s manufacturing footprint through, among other things, the closure of certain of its manufacturing plants. The contemplated closures will include asset write-down and write-off charges, severance and related benefits costs, and other exit and disposal costs. In connection with the planned closures, the Company expects to record total pre-tax plant closure and related asset impairment charges of between $12 million and $20 million in our fiscal fourth quarter of 2025 and into our fiscal year 2026.”
Transocean Ltd. announced a impairment with charges of approximately $1.9 billion affecting rigs classified as held for sale: Discoverer Clear Leader, Discoverer Americas, Deepwater Champion, Henry Goodrich and Discoverer India, as well as certain assets primarily associated with these rigs.
“the Company expects its third quarter 2025 results to include an estimated non-cash charge of approximately $1.9 billion associated with the impairment of these assets.”
Sight Sciences, Inc. announced a restructuring with charges of cash restructuring charge of approximately $2.7 million to $3.0 million primarily in the third quarter of 2025, consisting mostly of one-time employee severance affecting global operations, with specific changes in the United Kingdom (reduce its headcount by 43 employees, or approximately 20% of its global workforce, including up to four UK-based employ).
“On August 27, 2025, Sight Sciences, Inc. (the “Company”) informed its employees that it is implementing a targeted plan, commencing immediately, intended to reduce operating expenses, improve cost efficiencies, and better align its operating structure for long-term, profitable growth (the “Plan”).”
Indivior Pharmaceuticals, Inc. announced a restructuring with charges of approximately $39 to $50 million of restructuring charges pre-tax, of which $27-$35 million will be cash affecting enterprise-wide (pre-tax employee severance and related employee exit charges of approximately $16 to $19 million).
“which will be recognized in the third quarter of 2025. As a result of this initial initiative related to Phase 1, the Company expects to recognize a total of approximately $39 to $50 million of restructuring charges pre-tax, of which $27-$35 million will be cash, and which are expected to be recognized in the third and fourth quarters of 2025. These”
INTERNATIONAL PAPER CO /NEW/ announced a impairment with charges of between approximately $700 million and $900 million affecting Global Cellulose Fibers (GCF) business.
“In connection with the Transaction, on August 20, 2025, the Company determined that it expects to incur a non-cash impairment charge between approximately $700 million and $900 million, as a result of the sale price compared to the estimate of the current net asset value of the GCF business.”
INTERNATIONAL PAPER CO /NEW/ announced a restructuring with charges of aggregate pre-tax noncash asset write-off and accelerated depreciation charges of approximately $400 million and aggregate pre-tax cash severance and other shut affecting Containerboard business (approximately 680 employees).
“The Company plans to permanently close its containerboard mill and packaging facility in Savannah, Georgia. The containerboard mill will shut down in stages with all operations expected to cease by September 30, 2025. The closure is expected to reduce the Company’s containerboard capacity by approximately 1,000,000 tons. The Company estimates that the closure will result in aggregate pre-tax noncash asset write-off and accelerated depreciation charges of approximately $400 million and aggregate pre-tax cash severance and other shutdown charges of approximately $81 million, and anticipates that these charges will be recorded during the three months ending September 30, 2025. The Company expects closure of the containerboard mill to reduce its workforce by approximately 680 employees.”
INTERNATIONAL PAPER CO /NEW/ announced a restructuring with charges of aggregate pre-tax noncash asset write-off and accelerated depreciation charges of approximately $170 million and aggregate pre-tax cash severance and other shut affecting Containerboard business (approximately 300 employees).
“The Company plans to permanently close its containerboard, timber and lumber mills in Riceboro, Georgia. The containerboard mill will shut down in stages with all operations expected to cease by September 12, 2025. The closure is expected to reduce the Company’s containerboard capacity by approximately 430,000 tons. The Company estimates that the closure will result in aggregate pre-tax noncash asset write-off and accelerated depreciation charges of approximately $170 million and aggregate pre-tax cash severance and other shutdown charges of approximately $77 million, and anticipates that these charges will be recorded during the three months ending September 30, 2025. The Company expects closure of the containerboard mill to reduce its workforce by approximately 300 employees.”
T-REX Acquisition Corp. announced a impairment affecting data center in Orofino, Idaho (the Center).
“On July 23, 2025, our data center in Orofino, Idaho (the “Center”) was burglarized resulting in the theft of sixty-six obsolescent and fully depreciated S19ASIC miners and a portion of the electrical panel that controls the flow of electricity to the various power distribution units.”
LANDSTAR SYSTEM INC announced a impairment with charges of up to a $5.0 million affecting minority equity investment in Cavnue, LLC.
“the Company determined that it intends to record up to a $5.0 million non-cash impairment charge, or $0.11 per share, in the 2025 third quarter related to the Company’s non-controlling investment in Cavnue”
LANDSTAR SYSTEM INC announced a impairment with charges of $9.0 million affecting Blue TMS (transportation management system).
“the Company intends to wind-down the Blue TMS and record a $9.0 million non-cash impairment charge, or $0.20 per share in the 2025 third quarter”
LANDSTAR SYSTEM INC announced a impairment with charges of approximately $13 million to $17 million affecting Landstar Metro, S.A.P.I. de C.V. (Mexican subsidiary).
“the Company expects to record a non-cash impairment charge to goodwill and certain other assets of approximately $13 million to $17 million, or $0.28 to $0.37 per share, in the aggregate during the 2025 third quarter”
FATE THERAPEUTICS INC announced a restructuring with charges of approximately $0.9 million to $1.2 million (approximately 12%).
“On August 7, 2025, the Company’s Board of Directors approved a corporate restructuring to streamline operations, reduce operating expenses, and extend cash runway (the “Restructuring”). In connection with the Restructuring, the Company committed to a reduction in total workforce by approximately 12% (the “RIF”). Affected employees were informed on August 12, 2025. The Company expects the RIF to be completed during the third quarter of 2025, and estimates that it will incur charges of approximately $0.9 million to $1.2 million for severance and other employee termination-related costs during the third quarter of 2025.”
Oric Pharmaceuticals, Inc. announced a restructuring with charges of approximately $1.9 million affecting discovery research group (approximately 20% workforce reduction).
“On August 12, 2025, the Company initiated a strategic pipeline prioritization to focus operational and financial resources on the continued advancement of its two lead clinical programs, ORIC-944 and ORIC-114. This initiative will result in a substantial decrease in preclinical research, primarily from the elimination of the Company’s discovery research group. This will result in an approximately 20% workforce reduction and the Company expects to incur a one-time cost of approximately $1.9 million primarily related to termination benefits, including severance and healthcare-related benefits.”
MARAVAI LIFESCIENCES HOLDINGS, INC. announced a restructuring with charges of $8.0 million to $9.0 million affecting the Company's workforce (approximately 25% of the Company's workforce).
“On August 11, 2025, the Company announced an organizational restructuring, including a workforce reduction, to reduce operating costs. The workforce reduction, which is being implemented as part of a strategic cost-reduction initiative, was committed to by management on August 8, 2025 and is expected to impact approximately 25% of the Company’s workforce. In connection with the workforce reduction, the Company currently estimates it will incur restructuring and related costs in the range of $8.0 million to $9.0 million, consisting primarily of employee severance and benefits costs, the majority of which the Company expects to recognize in the second half of 2025.”
CarGurus, Inc. announced a restructuring with charges of approximately $14.0 million to $19.0 million affecting CarOffer, LLC (CarOffer), including the Dealer-to-Dealer and Instant Max Cash Offer products.
“The Company expects to incur total expenditures in the range of approximately $14.0 million to $19.0 million”
Nextdoor Holdings, Inc. announced a restructuring with charges of approximately $5 million.
“On August 7, 2025, the Company announced a cost reduction plan to accelerate the Company’s focus and efficiency (the “Cost Reduction Plan”). The Company currently estimates that it will incur one-time charges of approximately $5 million in connection with the Cost Reduction Plan, consisting primarily of cash expenditures for notice period and severance payments, employee benefits, and related costs.”
ALLURION TECHNOLOGIES, INC. announced a restructuring with charges of approximately $1.5 million (approximately 70 employees, or approximately 65% of its workforce).
“employees between August 4, 2025 and August 6, 2025. As part of this Restructuring Plan, the Company expects to incur severance and severance-related charges of approximately $1.5 million. The Company’s estimated restructuring charges is based on a number of assumptions. Actual results may differ materially and the Company may also incur other charges or cash”
BEYOND MEAT, INC. announced a restructuring with charges of One-time cash charges of $0.8 million to $1.3 million primarily consisting of severance payments, employee benefits and related costs in connection with reducti affecting North America (44 employees).
“On August 6, 2025, management of the Company approved a plan to reduce the Company’s current workforce in North America by approximately 44 employees, representing approximately 6% of the Company’s total global workforce. This decision was based on cost-reduction initiatives intended to reduce cost of goods sold and operating expenses. The Company estimates that it will incur one-time cash charges of approximately $0.8 million to $1.3 million in connection with the reduction in force, primarily consisting of severance payments, employee benefits and related costs, in all cases, provided to departing employees.”
Traeger, Inc. announced a restructuring with charges of between approximately $6.0 million and $8.0 million affecting the Company’s operations; closure of its office located in the United Kingdom (a reduction in force).
“the Board of Directors of Traeger approved a comprehensive enterprise initiative designed to streamline the Company’s organizational structure and rebalance its cost base to improve profitability and cash flow generation. As part of this initiative, the Company plans to identify opportunities to deliver cost savings and efficiencies. These savings are expected to be achieved through a multi-step strategic optimization plan (“Project Gravity”), which includes a reduction in force and the centralization (“Phase 1”) and streamlining of the Company’s operations (“Phase 2”). As part of Project Gravity, the Company has conducted a reduction in force and certain other steps, including the closure of its office located in the United Kingdom, in order to centralize its operations in Utah. The Company expects to incur pre-tax charges and future cash expenditures related to currently known and reasonably estimable actions of Project Gravity of between approximately $6.0 million and $8.0 million (”
ESTEE LAUDER COMPANIES INC announced a restructuring with charges of approximately $747 million (before tax) affecting supply chain, research and development, corporate functions, and brand-led model functions.
“the Company expects to record cumulative restructuring and other charges of approximately $747 million (before tax) in connection with initiatives approved since inception of the Restructuring Program through July 30, 2025”
COLGATE PALMOLIVE CO announced a restructuring with charges of between $200 and $300 million affecting Corporate segment.
“The Productivity Program is projected to result in cumulative pre-tax charges, once all initiatives are approved and implemented, totaling between $200 and $300 million over the course of the three-year program.”
ROGERS CORP announced a impairment with charges of $67.3 million affecting curamik business in AES operating segment.
“The higher charges were primarily due to a non-cash goodwill impairment charge of $67.3 million, resulting from the lowered outlook for the curamik ® business in our AES operating segment.”
ROGERS CORP announced a restructuring with charges of $12.0 million to $20.0 million affecting curamik reporting unit in AES operating segment.
“costs and operating expenses in excess of $13.0 million on an annual run-rate basis. As a result of these intended actions, we expect to record expenses in the range of $12.0 million to $20.0 million, which are expected to comprise of employee severance costs, property, plant and equipment relocation and reinstallation costs, consulting fees and other”
Merck & Co., Inc. announced a restructuring with charges of approximately $3.0 billion affecting sales and administrative organizations, research and development, global real estate footprint, manufacturing network.
“expected to be substantially completed by the end of 2029. The cumulative pretax costs to be incurred by the Company to implement the program are estimated to be approximately $3.0 billion, of which approximately 60% will be cash, relating primarily to employee separation expense and contractual termination costs. The remainder of the costs will be non-cash,”
Adaptimmune Therapeutics PLC announced a restructuring with charges of approximately $7-8 million (approximately 62%).
“On July 28, 2025, Adaptimmune announced a restructuring to support the continued development by US WorldMeds of TECELRA, lete-cel, afami-cel and uza-cel and to maximize value from the Company’s remaining assets, including its PRAME and CD-70 directed T-cell therapies (the “Restructuring”). Following the Transaction, the Company plans to further reduce its remaining workforce by approximately 62%. The planned reduction in workforce is subject to consultation with employee representatives in the United Kingdom regarding the plan. The Company anticipates that the majority of the reduction in workforce will be completed during the third quarter of 2025. As a result of these actions, the Company expects to incur pre-tax costs, relating to employee severance and other employee related costs, of approximately $7-8 million.”
Quanterix Corp announced a restructuring with charges of approximately $2.5 million.
“savings relate to headcount reductions, which are expected to be substantially completed in the third quarter of 2025. The Company expects to incur expenses of approximately $2.5 million, substantially all of which will be cash expenditures incurred in 2025 for severance. The Company’s estimates are based on a number of assumptions. Actual results may differ”
INTEL CORP announced a restructuring with charges of $1.9 billion of restructuring charges affecting enterprise-wide (reduce our core Intel workforce by 15% by the end of fiscal 2025).
“The Company expects these headcount reduction initiatives will reduce our core Intel workforce by 15% by the end of fiscal 2025. As a result of initiating and deploying the 2025 Restructuring Plan, the Company expects to recognize $1.9 billion of restructuring charges related to these actions, of which the Company is recognizing $1.8 billion in the second quarter of 2025.”
ROCKET PHARMACEUTICALS, INC. announced a restructuring with charges of approximately $3.5 million (approximately 30%).
“The Company began notifying affected employees on July 23, 2025, and expects the RIF to be completed by August 8, 2025. The Company estimates that it will incur approximately $3.5 million in restructuring and restructuring-related charges in the second half of 2025 in connection with the Plan, consisting primarily of employee severance payments and other”
Cibus, Inc. announced a restructuring with charges of approximately $0.5 million (approximately 34 full-time employees).
“funded commercial opportunities. The Company expects that the reduction in workforce will be completed by December 31, 2025, and estimates that it will incur approximately $0.5 million of one-time charges for accrued vacation and severance payments in the third quarter of 2025 in connection with this reduction in workforce. The Company communicated the”
Adicet Bio, Inc. announced a restructuring with charges of approximately $2.3 million (approximately 30% of the Company’s current employee base).
“On July 22, 2025, the Board of Directors of Adicet Bio, Inc. (the Company or Adicet) approved a reduction in its workforce by approximately 30% of the Company’s current employee base in connection with its strategic pipeline prioritization, as disclosed under Item 8.01 of this Current Report on Form 8-K. This workforce reduction will be substantially completed by the end of the third quarter of 2025. As a result of these actions, the Company expects to incur personnel-related restructuring charges of approximately $2.3 million in connection with one-time employee termination cash expenditures, including severance and other benefits, which are expected to be substantially incurred in the third quarter of 2025.”
EnerSys announced a restructuring with charges of $15 million to $20 million affecting corporate and management positions (approximately 575 employees, or 11% of its non-production global workforce).
“11%, or approximately 575 employees, and is focused primarily on corporate and management positions. EnerSys estimates one-time charges related to the Plan to be in the range of $15 million to $20 million. These charges are cash expenditures associated with the Plan, primarily consisting of severance payments, notice period payments in applicable jurisdictions,”
Quanterix Corp announced a restructuring with charges of approximately $3.3 million affecting Akoya Biosciences, Inc. (newly acquired subsidiary) (certain executives of the Company's newly acquired subsidiary, Akoya Biosciences, Inc.).
“costs and streamlined operations and are expected to result in annualized cash savings of approximately $2.8 million. The Company expects to incur expenses of approximately $3.3 million, substantially all of which will be cash expenditures incurred in 2025 for severance required under Akoya’s Executive Severance Plan. The Company’s estimates are based on a”
Clearside Biomedical, Inc. announced a restructuring with charges of approximately $3.4 million for severance and other employee termination-related costs affecting the Company (all Clearside employees).
“On July 17, 2025, Clearside Biomedical, Inc. (the “ Company ”) announced that it is exploring strategic alternatives to enhance shareholder value, and that in connection with such process and in order to extend the Company’s resources, the Company is implementing a plan pursuant to which all Clearside employees will have their employment with the Company terminated and will transition into consulting roles with the Company. The reduction in force is expected to be completed during the third quarter of 2025. The Company estimates that it will incur charges of approximately $3.4 million for severance and other employee termination-related costs in the third quarter of 2025.”
TechTarget, Inc. announced a restructuring with charges of approximately $19.5 million to $45.0 million (up to approximately 10% of the Company's current global colleague base).
“of up to approximately 10% of the Company’s current global colleague base. As a result of the Plan, the Company estimates that it will incur aggregate charges of approximately $19.5 million to $45.0 million, of which approximately $9.5 million to $15.0 million, consists primarily of cash employee-related costs, including notice and severance, employee benefits and”
Sarepta Therapeutics, Inc. announced a restructuring with charges of between approximately $32 million and $37 million (approximately 36% of the Company's workforce).
“on July 14, 2025, the Board of Directors of the Company (the “Board”) approved a reduction in force, representing approximately 36% of the Company’s workforce. As a result of this reduction in force, the Company estimates that it will record a one-time charge in the third quarter of 2025 related to employee termination benefits, including severance, between approximately $32 million and $37 million”
Jamf Holding Corp. announced a restructuring with charges of approximately $11.0 million to $12.5 million affecting go-to-market and other functions (approximately 6.4%).
“Today, July 15, 2025, the Company announced the Plan, which is intended to reduce operating costs, improve operating margins, allow for strategic reinvestment, and continue advancing the Company’s ongoing commitment to profitable growth. The Plan is expected to impact approximately 6.4% of the Company’s full-time employees. The Company currently estimates that it will incur charges of approximately $11.0 million to $12.5 million in connection with the Plan”
Pacira BioSciences, Inc. announced a restructuring with charges of approximately $2.4 million to $2.8 million affecting Science Center Campus in San Diego, California (71 employees or approximately 8% of the Company’s total workforce).
“8% of the Company’s total workforce. The Company currently estimates that it will recognize pre-tax charges to its third quarter 2025 financial results of approximately $2.4 million to $2.8 million related to employee termination benefits, consisting of garden leave and severance, healthcare benefits, and, to a lesser extent, other one-time termination”
Jasper Therapeutics, Inc. announced a restructuring with charges of approximately $1.8 million - $2.2 million affecting the Company (approximately 50%).
“in chronic urticaria and is halting other clinical and preclinical programs along with the reduction in workforce. The Company estimates that it will incur approximately $1.8 million - $2.2 million of cash expenditures in connection with the corporate reorganization, which relate to severance pay, and are expected to be incurred through the quarter ending”
DOW INC. announced a restructuring with charges of $630 million to $790 million affecting global asset footprint.
“costs. The Company will record a charge in the second quarter of 2025 for costs associated with these activities. In total, these costs are expected to be in the range of $630 million to $790 million and will consist of asset write-downs and write-offs ranging from $330 million to $360 million (and described more fully in Item 2.06), costs associated with exit”
Century Therapeutics, Inc. announced a restructuring with charges of approximately $3.7 million (approximately 51%).
“On July 1, 2025, the Board of Directors (the “ Board ”) of Century Therapeutics, Inc. (the “ Company ”) approved a reduction in force as part of a broader effort to right size the organization to focus on programs with the highest potential for transformational value. The Company expects to implement a net reduction of its employee headcount by approximately 51% (the “ RIF ”). As part of the RIF, the Company estimates that it will incur charges of approximately $3.7 million for severance and other employee termination-related costs.”
Warner Music Group Corp. announced a restructuring with charges of approximately $200 million on a pre-tax basis or approximately $150 million on an after-tax basis.
“The Company expects to incur total non-recurring charges of approximately $200 million on a pre-tax basis or approximately $150 million on an after-tax basis.”
TerrAscend Corp. announced a restructuring affecting Michigan market (approximately 21% of the Company’s workforce of approximately 1,200).
“On June 27, 2025, the board of directors of TerrAscend Corp. (together with TerrAscend Corp.’s consolidated entities, the “Company”) approved certain restructuring actions related to the Company’s exit from the Michigan market, aimed at enabling the Company to focus on its operations in its more profitable markets.”
BNB PLUS CORP. announced a restructuring with charges of approximately $300 thousand in one-time charges affecting Applied DNA Clinical Labs (ADCL); company-wide workforce reduction (approximately 27% of headcount).
“Company’s former Chairman and Chief Executive Officer. The projected annual payroll savings is expected to be partially offset by approximately three hundred thousand dollars ($300,000) in one-time charges related to the workforce reduction and ceasing of operations at ADCL, primarily for separation benefits. The Company expects to incur the majority of”
Bumble Inc. announced a restructuring with charges of approximately $13 million to $18 million of non-recurring charges (approximately 240 roles, representing approximately 30% of the Company's employees).
“On June 23, 2025, the Board of Directors of Bumble Inc. (the “Company”) approved a reduction in the Company’s global workforce by approximately 240 roles, representing approximately 30% of the Company’s employees, as the Company realigns its operating structure to optimize execution on its strategic priorities. As a result, the Company expects to incur approximately $13 million to $18 million of non-recurring charges, consisting primarily of employee severance, benefits, and related charges, for impacted employees.”
OUTFRONT Media Inc. announced a restructuring with charges of approximately $18.6 million (approximately 120 employees, or 6% of the Company’s total number of employees).
“Company expects the reduction in force associated with the Plan to be completed by the end of the second quarter of 2025. The Company estimates that it will incur approximately $18.6 million in total restructuring charges in connection with the Plan, consisting of severance payments, employee benefits and related costs and professional fees. The Company expects to”
AMARIN CORP PLCUK announced a restructuring with charges of between approximately $30 million and $37 million affecting Europe operations.
“On June 24, 2025, as described in the Press Release, the Company announced a global restructuring, with the vast majority of estimated cost savings from reduced commercialization expense from the Company’s Europe operations. The Company expects these actions will reduce operating costs by approximately $70 million annually and is anticipated to be substantially completed by June 30, 2026. Amarin anticipates that it will incur between approximately $30 million and $37 million in charges related to the restructuring, substantially all of which are cash expenditures for one-time termination benefits and associated costs.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.